This site is intended for healthcare professionals
Latest industry news

Forapin E

Last updated: 8th Dec 2025
Published: 8th Dec 2025
Author: Megan Lee

Forapin E was a topical analgesic ointment containing:

  • Lyophilized bee venom, standardized
  • Bornyl salicylate
  • Methyl nicotinate

It was indicated for the temporary relief of:

  • Rheumatic muscle and joint pain
  • Sciatica
  • Tendonitis and joint inflammation
  • Cold injuries
  • Prophylaxis and treatment of sports injuries

Forapin E is discontinued and no longer authorized or marketed in major regions. It is absent from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) databases, and no recent clinical trials or safety updates are available.

By Megan Lee

Developed by EPG Health for Medthority, independently of any sponsor.

Welcome:

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

How do you prefer to access medical updates and information?

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.